Medical application of catalpol and radix astragali extracting solution

A technology of astragalus extract and catalpol, applied in the field of medicine, can solve the problems of uncurable ALS, liver and kidney function damage, and difficult treatment, and achieve the effect of preventing or delaying motor neuron disease, delaying the onset time, and having a good market prospect

Inactive Publication Date: 2018-05-04
SOUTHWEST UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the unclear etiology and mechanism, the current treatment is extremely difficult
The only clinically used drug for the treatment of ALS is Riruta (the common name is riluzole tablets, the English name is riluzole tablets, and its chemical name is: 2-amino-6-trifluoromethoxybenzothiazole), but the Drugs cannot cure ALS, but can only delay the progression of the disease and prolong survival time
The results of clinical trials prove that riluzole can only prolong the life span of patients by 2-3 months in the treatment of ALS; moreover, the drug is extremely expensive, and the families of most patients cannot afford it; moreover, the drug can cause liver and kidney damage. The perspective of supplementing neurotrophic factors to treat ALS is not supported by clinical results, and most of the remaining therapeutic interventions are in the stage of preclinical animal experiments

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical application of catalpol and radix astragali extracting solution
  • Medical application of catalpol and radix astragali extracting solution
  • Medical application of catalpol and radix astragali extracting solution

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] The medicine for preventing or delaying motor neuron disease, nerve injury or / and degenerative disease and alleviating ALS, its raw material and preparation method are as follows:

[0024] Preparation method of Astragalus water extract: take Astragalus, add water equivalent to 8-10 times the weight of Astragalus and soak for 45 minutes, then heat and reflux extraction twice, each time for 1 hour, combine the extracts, and concentrate the extracts to 4 times the weight of Astragalus. times the concentrated solution to obtain the Radix Astragali water extract.

[0025] The preparation method of rehmannia glutinosa water extract: take the rehmannia glutinosa of the formula, add water equivalent to 8-10 times the weight of rehmannia glutinosa and soak for 45 minutes, then heat and reflux for extraction twice, each time for 1 hour, combine the extracts, and concentrate the extracts to the equivalent The concentrated solution of 4 times the weight of Rehmannia glutinosa is ob...

Embodiment 2

[0032] Pharmacodynamic investigation and evaluation of Astragalus root and Rehmannia glutinosa extracts in the treatment of amyotrophic lateral sclerosis (ALS), the specific methods are as follows: purchase 30 hSOD1-G93A transgenic mice and 6 wild type B6SJLF1 / J+ / + mice, The wild-type B6SJLF1 / J+ / + mice were used as the normal control NC group (n=6), and the hSOD1-G93A transgenic mice were randomly divided into 5 groups, which were named: ALS control group (n=6), positive drugs Luzole treatment group (Riluzole, n=6), Dihuang treatment group (catalpol 10mg / kg, n=6), Huangqi injection group (12g / kg, n=6), catalpol+Dihuang injection group (n =6). The specific grouping, dosage and method of administration are shown in Table 1:

[0033] Table 1. The specific grouping of experimental mice and the dosage and administration method

[0034]

[0035] Then evaluate their water intake and food intake every 4 days, and evaluate their food intake and body weight changes. The body weigh...

Embodiment 3

[0061] Establishment of animal model of sciatic nerve injury: the animals were anesthetized by intraperitoneal injection of 3.5% chloral hydrate at a dose of 0.1ml / 10g, after binding, routine disinfection and skin preparation. Cut open the skin with a scalpel blade and make a median longitudinal incision at the posterior part of the right femur, and suddenly separate the muscles to expose the sciatic nerve at the lower border of the piriformis muscle. The hemostat clamps the sciatic nerve to the third tooth, four times in total, 15 seconds each time. After completion, the nerve was returned and the skin was sutured. In the sham operation group, only the sciatic nerve was exposed without clamping, and then the wound was sutured.

[0062] Animal grouping and administration: 60 mice successfully modeled were randomly divided into five groups: sham operation group, model group, rehmannia glutinosa alcohol extract group (60g / kg), astragalus alcohol extract group (60g / kg, concentra...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses medical application of a catalpol and radix astragali extracting solution. According to the medical application disclosed by the invention, an experiment proves that a catalpoland radix astragali water extracting solution or alcohol extracting solution can prevent and control or delay a motor neurone disease and nerve injury; a result shows that by injecting a compositionof catalpol and radix astragali injection liquid, the disease time of amyotrophic lateral sclerosis can be delayed, the survival time is prolonged, an extremity motor function is obviously improved, the catalpol and radix astragali extracting solution has effects of resisting shrinkage on motor neuron cells of spinal cord anterior horn, maintaining or activating a growth state of the motor neuroncells, resisting neuronal apoptosis and protecting, has a function of increasing weight, and also has a good curative effect on a traumatic type nerve injury; moreover, the active ingredients of the catalpol and radix astragali extracting solution disclosed by the invention can be extracted from traditional Chinese medicines, and the used medicines are low in cost, easy to get and good in market prospect.

Description

[0001] This application is a divisional application with the application number 201610125031.9, the application date is March 4, 2016, and the invention title is "Medical Use of Catalpol and / or Astragalus Extract". technical field [0002] The invention belongs to the field of medicine, and in particular relates to the application of catalpol and astragalus extract in preventing or delaying motor neuron disease and / or nerve damage. Background technique [0003] Motor neuron disease (MND) is a group of chronic progressive neurodegenerative diseases of unknown etiology that selectively invade spinal cord anterior horn cells, brainstem motor neurons, cortical pyramidal cells and pyramidal tracts. According to different clinical manifestations, motor neuron disease can generally be divided into the following four types: amyotrophic lateral sclerosis (ALS); progressive muscular atrophy (PMA); progressive bulbar palsy (PBP); primary lateral Hardened (PLS). Its harmfulness lies in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/481A61P25/28A61P25/00A61K31/7048A61K36/804
CPCA61K31/7048A61K36/481A61K36/804A61K2236/331A61K2236/333A61K2300/00
Inventor 祝慧凤王园俸珊万东邱邴勋万果然
Owner SOUTHWEST UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap